For long trips across many time zones, count actual hours from your last dose, not local clock days
Product formulas, labels, packaging, and warnings may change over time
According to Diabetes Daily, a recent survey by Thrivable, a diabetes market research firm, demonstrated that people with type 1 diabetes who use GLP-1 drugs are far more likely to think positively about the future of diabetes treatment: 41.2 percent of GLP-1 users reported feeling optimistic, compared with a mere 5.6 percent of nonusers
Pituitary abnormalities in Prader-Willi syndrome and early onset morbid obesity
In Los Angeles, injection pricing is often significantly lower than IV therapy pricing